Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07521735 · ClinicalTrials.gov registry record
Next GEN - Philips Optimus
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 36
- Enrollment target
NCT07521735: Recruiting study, sponsored by Philips Clinical & Medical Affairs Global.
NCT07521735 is a clinical trial that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07521735 is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.
Primary Outcome
SpO2 accuracy will be evaluated for root-mean-square (rms) difference between the DUT and the reference for the specified SpO2 ranges (70-100%) and by SaO2 decade (90-100%, 80\<90%, 70-\<80%).
Interventions
- DEVICE Philips MR400 Pro MRI Patient Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2026-04-03 |
What NCT07521735 shows while recruiting
NCT07521735 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Philips MR400 Pro MRI Patient Monitor is the first listed.
NCT07521735 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07521735 about?
NCT07521735 is a clinical study titled "Next GEN - Philips Optimus". The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.
What is the current status of trial NCT07521735?
This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2026-03-09. Estimated completion is 2026-04-03.
What interventions are being tested in trial NCT07521735?
The interventions under investigation include: Philips MR400 Pro MRI Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT07521735?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI